Navigation Links
Novartis receives FDA approval of Tekamlo™, a single-pill combination of aliskiren and amlodipine to treat high blood pressure
Date:8/27/2010

eneral public pricing pressures; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About NovartisNovartis Pharmaceuticals Corporation researches, develops, manufactures and markets innovative prescription drugs used to treat a number of diseases and conditions, including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease and respiratory. The company's mission is to improve people's lives by pioneering novel healthcare solutions.

Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG, which provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in these areas. In 2009, the Group's continuing operations achieved net sales of USD 44.3 billion, while approximately USD 7.5 billion was invested in R&D activities throug
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
4. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
5. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
6. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
7. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
8. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
9. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
10. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
11. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic" or ... in China , today announced that ... issued by Shanghai RAAS Blood Products Co., Ltd. ("Shanghai ... that on May 21, 2013, Ms. Siu ... shareholders of the Company, and her spouse, Mr. Tung ...
(Date:5/24/2013)... , May 24, 2013  Auxilium Pharmaceuticals, Inc. (Nasdaq: ... will participate in the Deutsche Bank Health Care Conference ... Waterfront Hotel.  Mr. Adrian Adams , ... an overview of the Company and its product pipeline ...   (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) ...
(Date:5/24/2013)... YORK , May 24, 2013 In accordance ... Rules and Rule 14e-1 of the United States Exchange Act, ... its original offer for Elan Corporation (NYSE: ELN). ... Limited ("Royalty Pharma") made an offer for the entire of ... Corporation, plc ("Elan") (the "Original Offer").  On ...
Breaking Medicine Technology:China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9
... InfoLogix, Inc. (Pink Sheets: IFLG ), ... the healthcare and commercial industries, announced today that it ... Faire and Regional Conference, sponsored by HIMSS South Florida ... Grand Hotel in Davies, FL (situated North of Miami) ...
... Mass., Oct. 25 GENFIT (Alternext: ALGFT; ISIN: FR0004163111), ... and development, focusing on the early diagnosis and preventive ... it has been selected by Windhover as one of ... the cardiovascular/metabolic category. This announcement is part of the ...
Cached Medicine Technology:InfoLogix to Present at South Florida Healthcare Trade Faire & Regional Conference 2GENFIT Selected by Windhover for the 2011 'Top Biopharma Projects To Watch' 2GENFIT Selected by Windhover for the 2011 'Top Biopharma Projects To Watch' 3
(Date:5/24/2013)... 2013 IMED Mobility, a premier provider of ... Nashville recording artist Michelle Murray on Thursday, June 20th 2 p.m ... Finish Line” music and movie tour, which shares the story of ... on the track in 2000. Much of the film takes place ... the sport of INDYCAR racing despite suffering a crash that left ...
(Date:5/24/2013)... Los Angeles,Ca (PRWEB) May 24, 2013 ... and women courtesy of Dermasis.com. This new FDA registered ... ease the itching, burning and appearance of Psoriasis infected ... cream for men and women online. This soothing cream ... suffer from the burning, flaking and appearance of red ...
(Date:5/23/2013)... Angeles, CA (PRWEB) May 23, 2013 ... delivery has been gradually transforming, which has affected the ... medical school debt and seeking regular hours, more young ... joining hospitals or other medical groups,” says IBISWorld industry ... costs and reimbursement pressure, a number of older physicians ...
(Date:5/23/2013)... Magic often happens unexpectedly. "Howie Goes to ... twin five-year olds, Howie and his sister Heather, at ... in point. May 23, 2013 marks the debut of ... with the start of the Resort's "WeTime/MeTime” program, ... amenities and, most precious of all, opportunities for children and ...
(Date:5/23/2013)... May 24, 2013 Internationally recognized as ... in tennis for over 29 years, Coach Nick ... ATP & WTA players, Grand Slam winners, World #1’s; ... Champions, 25 USTA National Junior Champions, 8 Foreign National ... including Sunshine Cup, Orange Bowl and Eddie Herr winners ...
Breaking Medicine News(10 mins):Health News:Local Mobility Dealer Hosts Nashville Recording Artist 2Health News:Dermasis Psoriasis Treatment Cream for Men and Women Released Online at HealthCareSupplementz.com 2Health News:Medical Group Practice Management in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Medical Group Practice Management in the US Industry Market Research Report Now Available from IBISWorld 3Health News:New Children's Comic Book, "Howie Goes to Maui," Launches May 23, 2013 On Four Seasons Resort Maui's Web Site 2Health News:New Children's Comic Book, "Howie Goes to Maui," Launches May 23, 2013 On Four Seasons Resort Maui's Web Site 3Health News:Internationally Respected Tennis Coach, Nick Saviano Opens Summer Training Registration 2
... Wash., Feb. 13 Cardiac Science,Corporation (Nasdaq: ... diagnosis,resuscitation, rehabilitation, and informatics products, announced today,that it ... Annual OC Growth,Stock Conference on Wednesday, February 20, ... the company,s senior vice president and chief,financial officer, ...
... CORONA, Calif., Feb. 13 Watson,Pharmaceuticals, Inc. (NYSE: ... today that the U.S. Food and Drug Administration ... facilities. No,information regarding the duration or outcome of ... the Davie, Florida manufacturing facility has,been under Official ...
... Record Revenue and Earnings per Share for the ... leading,provider of clinical software, connectivity and information solutions ... for the three,months and year ended December 31, ... revenue for the three months ended December 31, ...
... marker for health status as common chronic ills , , WEDNESDAY, ... (PTSD) are as likely to have long-term health problems as ... study suggests. , The findings, published in the current edition ... , come from examining the health status of 4,462 male ...
... Mass., Feb. 13 Kelli Pedroia, wife,of Red Sox ... England as prom spokesperson. She will be speaking out ... a lot as a teenager, and a,year after her ... with stage 2,melanoma., (Photo: http://www.newscom.com/cgi-bin/prnh/20080213/DC14158 ), ...
... people are infected with noroviruses - commonly called stomach flu ... and diarrhea. While most people recover in a few days, ... cases, especially among the elderly and infants - death. ... School of Public Health have discovered that the virus mutates ...
Cached Medicine News:Health News:Cardiac Science to Present at the Roth Capital Partners 20th Annual Growth Stock Conference 2Health News:Watson Pharmaceuticals Announces FDA Inspection of Florida Facilities 2Health News:Allscripts Reports Fourth Quarter 2007 Results 2Health News:Allscripts Reports Fourth Quarter 2007 Results 3Health News:Allscripts Reports Fourth Quarter 2007 Results 4Health News:Allscripts Reports Fourth Quarter 2007 Results 5Health News:Allscripts Reports Fourth Quarter 2007 Results 6Health News:Allscripts Reports Fourth Quarter 2007 Results 7Health News:Allscripts Reports Fourth Quarter 2007 Results 8Health News:Allscripts Reports Fourth Quarter 2007 Results 9Health News:Allscripts Reports Fourth Quarter 2007 Results 10Health News:PTSD a Risk Factor for Long-Term Disease 2Health News:Kelli Pedroia, Wife of Red Sox Dustin Pedroia, Joins Melanoma Foundation of New England to Warn About Tanning for the Prom 2Health News:Vaccine for stomach flu may be possible, UNC research shows 2
10 mm angled tip with indentation on side and gently curved blade. Round knurled handle with polished finish. Indentation: right side....
Double ended with 0.5 mm by 10 mm and 0.5 mm by 15 mm blades. Both ends are sharp with gently curved blades. Square serrated handle with polished finish. Most popular size or model....
The popular Bechert nucleus rotator has been modified to have the shaft angled 10 mm from tip to bend for ease of manipulation of the lens nucleus in the anterior chamber. Round knurled handle....
Delicate membrane hook/pick with hook on side of instrument for engaging membranes. 20 gauge shaft with balanced titanium handle. Dark finish for reduced glare. Right....
Medicine Products: